To test the potential of RMC-6272 in hormone therapy-resistant breast cancers, we utilized a MCF-7 cell line that had been continuously treated with the ER modulator tamoxifen and obtained resistance to 10 μM of tamoxifen and harbor no mutations in ESR1, the gene encoding ERα [20]. The gene discussed is ESR1; the disease is breast carcinoma.